ALLEGRA-D
Identification of Allegra-D
| No description |
Google image searchProduct monograph
Active ingredients
fexofenadine hydrochloride, 60 MG
pseudoephedrine hydrochloride, 120 MG
DIN: 02239853
Dosage form(s): TABLET (IMMEDIATE AND EXTENDED RELEASE)
Route(s) of administration: ORAL
Schedule: OTC
Company: SANOFI CONSUMER HEALTH INC
Date: 31-JAN-2020
ATC:
- R01 — NASAL PREPARATIONS (ATC, ATC/DDD, )
- R01B — NASAL DECONGESTANTS FOR SYSTEMIC USE (ATC, ATC/DDD)
- R01BA — Sympathomimetics (ATC, ATC/DDD)
- R01BA52 — PSEUDOEPHEDRINE, COMBINATIONS (ATC/DDD)
Pharmaceutical standard: MFR
